Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| BCTX | BriaCell Therapeutics | $4.87 | -$6.06 | -55.45% | 5.2M | $21M | $4.75$98.20 |
| THH | TryHard | $37.00 | -$18.05 | -32.79% | 958.1K | $2.8B | $4.00$55.05 |
| IOTR | iOThree | $2.86 | -$1.12 | -28.09% | 385.1K | $10M | $2.24$59.80 |
| MLEC | Moolec Science | $3.79 | -$1.12 | -22.79% | 85.6K | $3.6M | $3.08$157.05 |
| TCOM | Trip.com Group | $62.38 | -$13.30 | -17.57% | 31.2M | $49B | $51.35$78.99 |
| GOVX | GeoVax Labs | $2.91 | -$0.58 | -16.52% | 269K | $6.0M | $2.87$57.88 |
| RVNL | GraniteShares ETF Trust - GraniteShares 2x Long Rivn Daily ETF | $43.51 | -$7.77 | -15.15% | 76.4K | - | $24.49$75.17 |
| APPX | Investment Managers Series Trust II - Tradr 2x Long App Daily ETF | $29.33 | -$5.00 | -14.56% | 2.2M | - | $6.74$52.54 |
| DTST | Data Storage | $4.39 | -$0.67 | -13.24% | 54.7K | $38M | $2.93$5.44 |
| FBIO | Fortress Biotech | $3.39 | -$0.51 | -13.08% | 2.4M | $121M | $1.33$4.53 |
Related Articles
Featured Article
Is This Fintech Growth Monster a Better Buy Than SoFi?
Neil Rozenbaum|Aug 28, 2025
SoFi has been crushing it this year, but here's another fintech company that is worthy of discussion.
Here's What's Helping Stocks Take Flight on Tuesday
Dan Caplinger|Jun 28, 2022
Good news on the economic front could help more than just one niche of the market.
Shares of Dave Have Surged 17% This Year. Here's Why I Don't Think the Surge Will Last
Bram Berkowitz|Feb 7, 2022
The digital banking app emerged from a blank-check company, dipped hard, and then surged.
Advertisement
Dave Will Have to Prove That It's Not Just Another Neo-Bank
David Moadel|Jan 31, 2022
As mobile-first personal finance apps become more mainstream, Dave will need more than a David-versus-Goliath story to beat competitors.
Why I'm Taking Goliath Over the Digital Banking App Dave
Bram Berkowitz|Jan 19, 2022
Dave initially received a $4 billion enterprise value, which looks way too high.
3 Things to Know About the Mark Cuban-Backed Fintech Dave
Bram Berkowitz|Jan 12, 2022
Dave recently started trading independently on the Nasdaq after merging with a blank-check company.
Can Evolus Disrupt the Botox Market?
Brett Schafer|Jul 3, 2021
This small-cap stock is going after a billion-dollar market.
Coronavirus: 2 Chinese Tourism Stocks to Sell
Will Ebiefung|Jun 30, 2020
These Chinese tourism companies will struggle in this uncertain economic environment.
Why Trip.com, Liberty Tripadvisor, and Melco Resorts Stocks All Popped 10% (or More) on Tuesday
Rich Smith|May 26, 2020
A vaccine will end the pandemic, encouraging travel, and boosting attendance at resorts -- or so the theory goes.
3 Top Chinese Stocks to Watch in April
Will Ebiefung|Apr 9, 2020
The coronavirus pandemic battered the Chinese economy. But these three stocks may benefit from a potential rebound in April.
